The quadrivalent human papillomavirus vaccine
Wheat, A.
Medicine and Health Rhode Island 91(12): 387-389
2008
ISSN/ISBN: 1086-5462 PMID: 19170317 Document Number: 615580
Document emailed within 1 workday
Related Documents
Villa, L.L.; Costa, R.L.R.; Petta, C.A.; Andrade, R.P.; Ault, K.A.; Giuliano, A.R.; Wheeler, C.M.; Koutsky, L.A.; Malm, C.; Lehtinen, M.; Skjeldestad, F.Egil.; Olsson, S-Eric.; Steinwall, M.; Brown, D.R.; Kurman, R.J.; Ronnett, B.M.; Stoler, M.H.; Ferenczy, A.; Harper, D.M.; Tamms, G.M.; Yu, J.; Lupinacci, L.; Railkar, R.; Taddeo, F.J.; Jansen, K.U.; Esser, M.T.; Sings, H.L.; Saah, A.J.; Barr, E. 2005: Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet. Oncology 6(5): 271-278Townsend, J.S.; Steele, C.Brooke.; Hayes, N.; Bhatt, A.; Moore, A.R. 2017: Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program Journal of Women's Health 26(3): 200-206
Brown, B.; Blas, M.M.; Heidari, O.; Carcamo, C.; Halsey, N.A. 2013: Reported changes in sexual behaviour and human papillomavirus knowledge in Peruvian female sex workers following participation in a human papillomavirus vaccine trial International Journal of Std and Aids 24(7): 531-535
Moscarini, M.; Lukic, A.; Franco, C. 2004: Anti human papillomavirus vaccine: the checkmate to human papillomavirus? European Journal of Gynaecological Oncology 25(2): 151-156
La Vincente, S.F.; Mielnik, D.; Jenkins, K.; Bingwor, F.; Volavola, L.; Marshall, H.; Druavesi, P.; Russell, F.M.; Lokuge, K.; Mulholland, E.K. 2015: Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents Bmc Public Health 15: 1257
Davidson, B.L. 1998: A quadrivalent rotavirus vaccine New England Journal of Medicine 338(9): 621; Author Reply 621-622
Vanni, T.; Luz, P.M.; Foss, A.; Mesa-Frias, M.; Legood, R. 2012: Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach Vaccine 30(32): 4866-4871
Franceschi, S. 2002: Human papillomavirus: a vaccine against cervical carcinoma uterine Epidemiologia e Prevenzione 26(3): 140-144
Savoy, M. 2014: An opportunity for improvement: adolescent administration of the human papillomavirus vaccine Delaware Medical Journal 86(2): 53-55
Jacobson, R.M. 2014: Making the C.A.S.E. for the human papillomavirus vaccine: how to talk to parents and adolescents Minnesota Medicine 97(2): 38-42
Dinh, T.A.; Rosenthal, S.L.; Doan, E.D.; Trang, T.; Pham, V.H.; Tran, B.D.; Tran, V.D.; Phan, G.A.B.; Chu, H.K.H.; Breitkopf, C.R. 2007: Attitudes of mothers in da Nang, Vietnam toward a human papillomavirus vaccine Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 40(6): 559-563
Nghi, N.Q.; Lamontagne, D.S.; Bingham, A.; Rafiq, M.; Mai, L.T.P.; Lien, N.T.P.; Khanh, N.C.; Hong, D.T.; Huyen, D.T.T.; Tho, N.T.T.; Hien, N.T. 2010: Human papillomavirus vaccine introduction in Vietnam: formative research findings Sexual Health 7(3): 262-270
Hariharan, I.; Pillai, M.R. 2009: Genotypes of the human papillomavirus: relevance to Indian field trials of the vaccine Indian Journal of Medical Research 130(3): 247-260
Nghi, N.Q.; Lamontagne, D.S.; Bingham, A.; Rafiq, M.; Mai, L.T.P.; Lien, N.T.P.; Khanh, N.C.; Hong, D.T.; Huyen, D.T.T.; Tho, N.T.T.; Hien, N.T. 2010: Human papillomavirus vaccine introduction in Vietnam: formative research findings Sexual Health 7(3): 262-270
Migone, C.; Barrett, T.; Cotter, S.; Clarke, A.; Corcoran, B. 2017: The Uptake of Human Papillomavirus Vaccine in Irish Schools: the Impact of Disadvantage Irish Medical Journal 110(7): 603
Tomljenovic, L.; Shaw, C.A. 2013: Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Annals of Medicine 45(2): 182-193
Fonseca, A.J.d.; Ferreira, L.C.d.L.; Neto, G.B. 2013: Cost-effectiveness of the vaccine against human papillomavirus in the Brazilian Amazon region Revista da Associacao Medica Brasileira 59(5): 442-451
Biellik, R.; Levin, C.; Mugisha, E.; LaMontagne, D.S.; Bingham, A.; Kaipilyawar, S.; Gandhi, S. 2009: Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings Vaccine 27(44): 6203-6209
Wang, S-Ming.; Zhang, S-Kai.; Pan, X-Fei.; Ren, Z-Fang.; Yang, C-Xia.; Wang, Z-Zhen.; Gao, X-Hong.; Li, M.; Zheng, Q-Qing.; Ma, W.; Zhao, F-Hui.; Qiao, Y-Lin.; Sivasubramaniam, P. 2014: Human papillomavirus vaccine awareness, acceptability, and decision-making factors among Chinese college students Asian Pacific journal of cancer prevention: APJCP 15(7): 3239-3245
Juntasopeepun, P.; Suwan, N.; Phianmongkhol, Y.; Srisomboon, J. 2012: Factors influencing acceptance of human papillomavirus vaccine among young female college students in Thailand International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 118(3): 247-250